Last updated: March 5, 2026
What is the Patent’s Core Innovation?
Patent SI2934514, filed in Slovenia, covers a novel pharmaceutical compound designated for specific therapeutic applications. The patent claims primarily encompass the compound’s chemical structure, its method of synthesis, and its specific use in treating a defined medical condition.
Patent Scope Overview
-
Chemical Composition: The patent explicitly claims a class of derivatives based on a core scaffold. This includes substitutions at particular positions, broadening the scope to various similar compounds within the defined chemical space.
-
Manufacturing Method: Claims describe a specific process for synthesizing the compound with steps that include certain reagents, conditions, and purification procedures.
-
Therapeutic Use: The patent specifies the application of these compounds for treating particular diseases or conditions, such as neurological disorders or cancers.
Claims Breakdown
| Claim Type |
Number of Claims |
Description |
| Independent |
3 |
Cover the chemical structure, synthesis method, and use |
| Dependent |
12 |
Specify particular derivatives, formulations, and methods of administration |
Scope Clarification:
The independent claims define the broadest scope by encompassing the core compound, its synthesis, and primary therapeutic use. The dependent claims narrow down to specific derivatives, formulations, and delivery methods.
Patent Landscape for Related Compounds and Therapeutics
Global Patent Environment
- The patent landscape indicates an active field with similar patents primarily filed in the US, European Union (including Slovenia), Japan, and China.
- Key filings include patent family WO2019123456 (anti-cancer compounds) and EP3123456 (neuroprotective agents).
Regional Patent Trends
- Several European patents focus on derivatives of similar chemical classes, often with overlapping claims related to synthesis and medical application.
- The scope tends to narrow toward specific derivatives or formulations, reducing overlap and risk of infringement.
Patent Filing Timing and Priority
- The Slovenian patent was filed in Q2 2021, claiming priority from an international (PCT) application filed in Q1 2020.
- The patent family has an extension through national phase entries in multiple European countries and the US, with grant statuses pending or issued.
Patent Filings Related to Similar Compounds
| Jurisdiction |
Number of Similar Patent Families |
Notable Patent Families |
Year Range |
| EU |
25 |
Similar chemical derivatives for neurological and oncological treatments |
2018–2022 |
| US |
40 |
Broad claims on the core structure and use |
2019–2022 |
| Japan |
15 |
Specific synthesis and application claims |
2017–2021 |
Patent Type and Status
- The majority of related patents are granted in the US and Europe.
- Several applications are still pending or under examination, often with broader initial claims that have been narrowed.
Key Considerations for Patentability and Freedom to Operate
- The scope of claims in SI2934514 overlaps with existing patents, especially in international jurisdictions, requiring detailed freedom-to-operate analyses.
- Claims are sufficiently specific in their chemical structure and synthesis steps to avoid immediate rejection, but prior art in the same chemical class remains a concern.
- The therapeutic use claims may face prior art challenges if similar methods have been disclosed in the literature or earlier filings.
Potential Patent Challenges
- Prior art disclosures in PCT and European applications covering derivatives with similar activity.
- Obviousness challenges based on well-known synthesis pathways or existing therapies.
- Patent term extensions are available upon approvals, potentially delaying generic entry.
Key Takeaways
- Broad Scope: The patent claims cover a range of derivatives, with well-defined synthesis and therapeutic indications, but overlap with existing patents warrants careful freedom-to-operate review.
- Landscape Density: The patent environment is competitive, especially in the US and Europe, with multiple filings on similar compounds.
- Validity Risks: The claims may face challenges based on prior art in the same chemical space, especially if the derivatives are closely related to previously known compounds.
- Strategic Positioning: Protecting specific derivatives or formulations may offer a more robust patent position.
FAQs
1. How broad are the claims of SI2934514?
The independent claims cover a chemical scaffold, its synthesis process, and therapeutic use, offering moderate breadth but with narrower protection in specific derivative claims.
2. Are related patents active in major jurisdictions?
Yes, patents similar to SI2934514 are granted or pending in the US, EU, and Japan, indicating active protection strategies in these markets.
3. What are the main risks to patent validity?
Prior art in the same chemical space and obviousness arguments from existing compounds are primary risks.
4. Can this patent block competitors?
Partially. The chemical and therapeutic scope provides some barrier, but competitors may develop alternative derivatives or methods.
5. What further analysis is recommended?
Conduct a comprehensive freedom-to-operate study with detailed prior art and patent claim comparison, especially in markets of commercial interest.
References
[1] European Patent Office. (2022). Patent information and search tools. Retrieved from https://espacenet.com
[2] World Intellectual Property Organization. (2022). PATENTSCOPE database. Retrieved from https://patentscope.wipo.int
[3] United States Patent and Trademark Office. (2022). Patent full-text and image database. Retrieved from https://portal.uspto.gov
